Effects of orally administered lactoferrin and lactoperoxidase on symptoms of the common cold
- PMID: 30202407
- PMCID: PMC6124826
Effects of orally administered lactoferrin and lactoperoxidase on symptoms of the common cold
Abstract
Objectives: Lactoferrin (LF) and lactoperoxidase (LPO) are present in human saliva. LF has been demonstrated to show antibacterial and antiviral activities. In saliva, LPO catalyzes the hydrogen peroxide-dependent oxidation of thiocyanate to hypothiocyanite that exhibits antimicrobial and antiviral properties. A randomized, open-label, parallel-group clinical trial was conducted to examine the effectiveness of sucking tablets containing LF and LPO (LF+LPO) in alleviating symptoms of the common cold and/or influenza infection.
Methods: A total of 407 subjects were randomized into two groups, treatment and non-treatment groups, and each group was further classified into subgroups habitually wearing a face mask, washing their hands, or gargling. The common cold, influenza, and gastrointestinal symptoms were used to evaluate the effectiveness, and the incidence and duration of symptoms were statistically analyzed.
Results: The incidence and duration of common cold, gastrointestinal symptoms, and influenza infection were not statistically different between treatment and non-treatment groups. LF+LPO tablets were moderately effective in reducing the incidence and duration of common cold symptoms in the subgroup that did not gargle and especially to shorten significantly the duration of fever higher than 38°C in the subgroup that did not wear a face mask.
Conclusion: The results suggested that the effect of ingestion of the tablet is not obvious in alleviating common cold symptoms but may be helpful when the subjects do not follow precautionary measures such as gargling and the use of a protective face mask.
Keywords: Common cold syndromes; face mask; gargling; lactoferrin; lactoperoxidase.
Figures
References
-
- Pappas DE, Hendley JO, Hayden FG, Winther B. Symptom profile of common colds in school-aged children. Pediatr Infect Dis J. 2008;27:8–11. - PubMed
-
- Wakabayashi H, Yamauchi K, Takase M. Lactoferrin research, technology and applications. Int Dairy J. 2006;16:1241–51.
-
- Wakabayashi H, Kondo I, Kobayashi T, Yamauchi K, Toida T, Iwatsuki K, et al. Periodontitis, periodontophathic bacteria and lactoferrin. Biometals. 2010;23:419–24. - PubMed
-
- Thomas EL, Bozeman PM, Learn DB. Lactoperoxidase:Structure and catalytic properties. In: Everse J, Everse KE, Grisham MB, editors. Peroxidases in Chemistry and Biology. Vol. 1. Boca Raton, Florida: CRC Press; 1991. pp. 123–42.
LinkOut - more resources
Full Text Sources